Literature DB >> 24849511

CRISPR/Cas technology: a revolutionary approach for genome engineering.

LinLin Zhang1, Qi Zhou.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24849511     DOI： 10.1007/s11427-014-4670-x

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
  6 in total

Review 1.  CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.

Authors:  Muhammad R Javed; Maria Sadaf; Temoor Ahmed; Amna Jamil; Marium Nawaz; Hira Abbas; Anam Ijaz
Journal:  Curr Microbiol       Date:  2018-08-04       Impact factor: 2.188

2.  CRISPR as a driving force: the Model T of biotechnology.

Authors:  Carlos Mariscal; Angel Petropanagos
Journal:  Monash Bioeth Rev       Date:  2016-06

3.  Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs.

Authors:  Ping Xu; Zhiheng Liu; Ying Liu; Huazheng Ma; Yiyuan Xu; Ying Bao; Shiyou Zhu; Zhongzheng Cao; Zeguang Wu; Zhuo Zhou; Wensheng Wei
Journal:  Nat Biotechnol       Date:  2021-06-21       Impact factor: 54.908

Review 4.  The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops.

Authors:  Surender Khatodia; Kirti Bhatotia; Nishat Passricha; S M P Khurana; Narendra Tuteja
Journal:  Front Plant Sci       Date:  2016-04-19       Impact factor: 5.753

Review 5.  Application of CRISPR/Cas9 Genome Editing Technology for the Improvement of Crops Cultivated in Tropical Climates: Recent Progress, Prospects, and Challenges.

Authors:  Effi Haque; Hiroaki Taniguchi; Md Mahmudul Hassan; Pankaj Bhowmik; M Rezaul Karim; Magdalena Śmiech; Kaijun Zhao; Mahfuzur Rahman; Tofazzal Islam
Journal:  Front Plant Sci       Date:  2018-05-08       Impact factor: 5.753

6.  Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRISPR/Cas9 and other genomic editing technologies.

Authors:  David Fajardo-Ortiz; Annie Shattuck; Stefan Hornbostel
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.